The latest closing stock price for Allogene Therapeutics as of January 21, 2025 is 1.84.
An investor who bought $1,000 worth of Allogene Therapeutics stock at the IPO in 2018 would have $-926 today, roughly -1 times their original investment - a -35.26% compound annual growth rate over 6 years.
The all-time high Allogene Therapeutics stock closing price was 54.04 on May 22, 2020.
The Allogene Therapeutics 52-week high stock price is 5.78, which is 214.1% above the current share price.
The Allogene Therapeutics 52-week low stock price is 1.78, which is 3.3% below the current share price.
The average Allogene Therapeutics stock price for the last 52 weeks is 2.99.
An investor who bought $1,000 worth of Allogene Therapeutics stock at the IPO in 2018 would have $-926 today, roughly -1 times their original investment - a -35.26% compound annual growth rate over 6 years.
The all-time high Allogene Therapeutics stock closing price was 54.04 on May 22, 2020.
The Allogene Therapeutics 52-week high stock price is 5.78, which is 214.1% above the current share price.
The Allogene Therapeutics 52-week low stock price is 1.78, which is 3.3% below the current share price.
The average Allogene Therapeutics stock price for the last 52 weeks is 2.99.